$33.66
0.21%
Nasdaq, Aug 29, 10:01 pm CET
ISIN
US79957L1008
Symbol
SMTI

Sanara MedTech Inc Stock price

$33.66
+8.64 34.53% 1M
-1.03 2.97% 6M
+0.46 1.39% YTD
-1.85 5.21% 1Y
+1.01 3.09% 3Y
+6.66 24.67% 5Y
+25.67 321.28% 10Y
-17.34 34.00% 20Y
Nasdaq, Closing price Fri, Aug 29 2025
-0.07 0.21%

Key metrics

Basic
Market capitalization
$299.7m
Enterprise Value
$326.7m
Net debt
$27.0m
Cash
$17.0m
Shares outstanding
8.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
3.1 | 2.8
EV/Sales
3.4 | 3.0
EV/FCF
8,166.3
P/B
8.6
Financial Health
Equity Ratio
44.3%
Return on Equity
-24.8%
ROCE
-5.2%
ROIC
-
Debt/Equity
1.3
Financials (TTM | estimate)
Revenue
$97.4m | $107.9m
EBITDA
$30.0k | -
EBIT
$-4.4m | $-7.7m
Net Income
$-9.9m | $-8.9m
Free Cash Flow
$40.0k
Growth (TTM | estimate)
Revenue
34.5% | 24.5%
EBITDA
-50.0% | -
EBIT
-3.6% | -97.2%
Net Income
-51.5% | 7.9%
Free Cash Flow
101.3%
Margin (TTM | estimate)
Gross
91.8%
EBITDA
0.0% | -
EBIT
-4.5%
Net
-10.2% | -8.3%
Free Cash Flow
0.0%
More
EPS
$-1.2
FCF per Share
$0.0
Short interest
5.8%
Employees
141
Rev per Employee
$610.0k
Show more

Is Sanara MedTech Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Sanara MedTech Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Sanara MedTech Inc forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Sanara MedTech Inc forecast:

Buy
88%
Hold
13%

Financial data from Sanara MedTech Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
97 97
35% 35%
100%
- Direct Costs 8.01 8.01
8% 8%
8%
89 89
38% 38%
92%
- Selling and Administrative Expenses 84 84
30% 30%
86%
- Research and Development Expense - -
-
-
0.03 0.03
50% 50%
0%
- Depreciation and Amortization 4.43 4.43
3% 3%
5%
EBIT (Operating Income) EBIT -4.40 -4.40
4% 4%
-5%
Net Profit -9.94 -9.94
52% 52%
-10%

In millions USD.

Don't miss a Thing! We will send you all news about Sanara MedTech Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sanara MedTech Inc Stock News

Neutral
GlobeNewsWire
5 days ago
FORT WORTH, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skin markets, today announced that management will present at the ...
Neutral
Seeking Alpha
19 days ago
Sanara MedTech Inc. (NASDAQ:SMTI ) Q2 2025 Earnings Call August 13, 2025 8:00 AM ET Company Participants Elizabeth B. Taylor - Chief Financial Officer Ronald T.
Neutral
GlobeNewsWire
19 days ago
Net Revenue Increased  28% Year-Over-Year in Q2; Increased 27% Year-Over-Year in First Six Months of 2025 Announces Process to Evaluate Strategic Alternatives for its Tissue Health Plus, LLC Subsidiary FORT WORTH, TX, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commerc...
More Sanara MedTech Inc News

Company Profile

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.

Head office United States
CEO Ron Nixon
Employees 141
Founded 1982
Website sanaramedtech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today